Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Soleno Therapeutics Inc | 93,002 | 284,152 | +191,150 | $6.64M | $23.81M | 14.80% | +$17.16M |
| Amgen Inc.(AMGN) | 0 | 52,100 | +52,100 | $0 | $14.55M | 9.04% | +$14.55M |
| TG Therapeutics, Inc.(TGTX) | 207,883 | 371,448 | +163,565 | $8.20M | $13.37M | 8.31% | +$5.17M |
| Neurocrine Biosciences, Inc.(NBIX) | 62,247 | 94,042 | +31,795 | $6.88M | $11.82M | 7.35% | +$4.94M |
| Eli Lilly and Company(LLY) | 19,302 | 14,816 | -4,486 | $15.94M | $11.55M | 7.18% | -$4.39M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 87,189 | 104,473 | +17,284 | $10.82M | $11.09M | 6.89% | +$262.2K |
| BioMarin Pharmaceutical Inc.(BMRN) | 52,877 | 192,877 | +140,000 | $3.74M | $10.60M | 6.59% | +$6.86M |
| Vaxcyte, Inc.(PCVX) | 92,385 | 198,285 | +105,900 | $3.49M | $6.45M | 4.01% | +$2.96M |
| Viking Therapeutics, Inc.(VKTX) | 104,121 | 197,468 | +93,347 | $2.51M | $5.23M | 3.25% | +$2.72M |
| Vertex Pharmaceuticals Incorporated(VRTX) | 0 | 10,000 | +10,000 | $0 | $4.45M | 2.77% | +$4.45M |
| Protagonist Therapeutics Inc | 0 | 76,185 | +76,185 | $0 | $4.21M | 2.62% | +$4.21M |
| Gilead Sciences, Inc.(GILD) | 0 | 30,000 | +30,000 | $0 | $3.33M | 2.07% | +$3.33M |
| argenx SEADR(ARGX) | 12,279 | 5,974 | -6,305 | $7.18M | $3.29M | 2.05% | -$3.89M |
| Immunocore Holdings plcADS(IMCR) | 96,984 | 104,384 | +7,400 | $2.88M | $3.28M | 2.04% | +$398.1K |
| Regeneron Pharmaceuticals, Inc.(REGN) | 29,828 | 5,607 | -24,221 | $18.92M | $2.94M | 1.83% | -$15.97M |
| Revolution Medicines, Inc.(RVMD) | 0 | 79,079 | +79,079 | $0 | $2.91M | 1.81% | +$2.91M |
| Cogent Biosciences, Inc.(COGT) | 392,213 | 392,213 | 0 | $2.35M | $2.82M | 1.75% | +$466.7K |
| Scholar Rock Holding Corporation(SRRK) | 57,923 | 62,926 | +5,003 | $1.86M | $2.23M | 1.39% | +$366.6K |
| Iteos Therapeutics Inc | 0 | 206,200 | +206,200 | $0 | $2.06M | 1.28% | +$2.06M |
| UroGen Pharma Ltd.(URGN) | 76,220 | 150,000 | +73,780 | $843.0K | $2.06M | 1.28% | +$1.21M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 53,985 | +53,985 | $0 | $1.96M | 1.22% | +$1.96M |
| Viridian Therapeutics, Inc.(VRDN) | 162,063 | 122,061 | -40,002 | $2.18M | $1.71M | 1.06% | -$478.2K |
| Merck & Co., Inc.(MRK) | 0 | 20,000 | +20,000 | $0 | $1.58M | 0.98% | +$1.58M |
| Pacira BioSciences, Inc.(PCRX) | 38,926 | 58,926 | +20,000 | $967.3K | $1.41M | 0.88% | +$441.0K |
| Olema Pharmaceuticals, Inc.(OLMA) | 100,000 | 253,657 | +153,657 | $376.0K | $1.08M | 0.67% | +$704.6K |
| Reviva Pharmaceutcls Hldgs I | 650,723 | 2,735,457 | +2,084,734 | $620.7K | $1.04M | 0.65% | +$421.8K |
| Mind Medicine Mindmed Inc | 0 | 158,536 | +158,536 | $0 | $1.03M | 0.64% | +$1.03M |
| Trevi Therapeutics, Inc.(TRVI) | 180,000 | 185,830 | +5,830 | $1.13M | $1.02M | 0.63% | -$115.7K |
| Terns Pharmaceuticals Inc | 56,098 | 259,852 | +203,754 | $154.8K | $969.2K | 0.60% | +$814.4K |
| 89bio Inc | 231,436 | 98,382 | -133,054 | $1.68M | $966.1K | 0.60% | -$716.4K |
| Climb Bio, Inc.(CLYM) | 669,803 | 702,135 | +32,332 | $817.2K | $870.6K | 0.54% | +$53.5K |
| Scpharmaceuticals Inc | 0 | 217,623 | +217,623 | $0 | $829.1K | 0.52% | +$829.1K |
| Vistagen Therapeutics, Inc.(VTGN) | 565,975 | 403,922 | -162,053 | $1.41M | $807.8K | 0.50% | -$607.1K |
| Arvinas, Inc.(ARVN) | 0 | 96,455 | +96,455 | $0 | $709.9K | 0.44% | +$709.9K |
| Apogee Therapeutics Inc | 40,000 | 10,572 | -29,428 | $1.49M | $459.1K | 0.29% | -$1.04M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 0 | 40,294 | +40,294 | $0 | $386.4K | 0.24% | +$386.4K |
| Nuvalent Inc | 0 | 5,000 | +5,000 | $0 | $381.5K | 0.24% | +$381.5K |
| Alector Inc | 456,546 | 266,023 | -190,523 | $561.6K | $372.4K | 0.23% | -$189.1K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 207,694 | 157,694 | -50,000 | $276.2K | $321.7K | 0.20% | +$45.5K |
| Replimune Group, Inc.(REPL) | 74,530 | 32,483 | -42,047 | $726.7K | $301.8K | 0.19% | -$424.9K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 64,613 | 64,613 | 0 | $219.0K | $175.1K | 0.11% | -$43.9K |
| Relay Therapeutics, Inc.(RLAY) | 426,346 | 43,616 | -382,730 | $1.12M | $150.9K | 0.09% | -$966.1K |
| Elevation Oncology Inc | 0 | 362,935 | +362,935 | $0 | $133.2K | 0.08% | +$133.2K |
| PureTech Health plcADS(PRTCY) | 0 | 7,324 | +7,324 | $0 | $126.3K | 0.08% | +$126.3K |
| Summit Therapeutics Inc.(SMMT) | 0 | 932 | +932 | $0 | $19.8K | 0.01% | +$19.8K |
| Zai Lab LimitedADR(ZLAB) | 0 | 3,785 | +3,785 | $0 | $13.2K | 0.01% | +$13.2K |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 13,115 | 0 | -13,115 | $3.54M | $0 | — | -$3.54M |
| Ascendis Pharma A/SADR(ASND) | 8,321 | 0 | -8,321 | $1.30M | $0 | — | -$1.30M |
| Candel Therapeutics, Inc.(CADL) | 25,045 | 0 | -25,045 | $141.5K | $0 | — | -$141.5K |
| Centessa Pharmaceuticals PlcADS | 164,048 | 0 | -164,048 | $2.36M | $0 | — | -$2.36M |
| Cytokinetics, Incorporated(CYTK) | 20,000 | 0 | -20,000 | $803.8K | $0 | — | -$803.8K |
| Gossamer Bio, Inc.(GOSS) | 269,589 | 0 | -269,589 | $296.5K | $0 | — | -$296.5K |
| Kalvista Pharmaceuticals Inc | 135,509 | 0 | -135,509 | $1.56M | $0 | — | -$1.56M |
| Mereo BioPharma Group plcADS(MREO) | 492,215 | 0 | -492,215 | $168.5K | $0 | — | -$168.5K |
| Novo Nordisk A/SADR(NVO) | 24,618 | 0 | -24,618 | $1.68M | $0 | — | -$1.68M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 50,000 | 0 | -50,000 | $2.65M | $0 | — | -$2.65M |
| Sage Therapeutics Inc | 183,466 | 0 | -183,466 | $1.46M | $0 | — | -$1.46M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 46,019 | 0 | -46,019 | $150.0K | $0 | — | -$150.0K |
| Springworks Therapeutics Inc | 60,000 | 0 | -60,000 | $2.65M | $0 | — | -$2.65M |
| uniQure N.V.SHS(QURE) | 36,500 | 0 | -36,500 | $386.9K | $0 | — | -$386.9K |